Ipamorelin is the first selective GH secretagogue
Protocol approach 3: comprehensive repair (thymosin alpha-1 plus BPC-157 plus TB-500) Goal: Immune rebalancing combined with aggressive tissue repair Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week BPC-157: 250 mcg subcutaneously twice daily near affected tissue TB-500 : 2-5 mg subcutaneously twice per week for loading, then weekly for maintenance Rationale: This three-peptide approach targets immune regulation (TA1), mucosal and tissue healing (BPC-157), and cellular migration plus repair (TB-500)
In studies where beta-3 receptors were genetically deleted, AOD-9604 lost its fat-reducing effects, confirming the critical role of this pathway
Topical vs Injectable Tolerability Topical GHK-Cu appears better tolerated than injectable forms, with topical side effects typically limited to mild redness, itching, or irritation at application site and rare copper uglies phenomenon (anecdotal accelerated skin aging appearance due to potential MMP upregulation, not well-studied)
Some research protocols combine both approaches for maximum metabolic correction
But three specific peptides stand out for their direct action on pineal gland function and sleep architecture: Pinealon, Epitalon, and DSIP